Overview

Treatment for Post Acute COVID-19 Syndrome

Status:
Not yet recruiting

Trial end date:
2023-12-01

Target enrollment:

Participant gender:

Summary

Post-acute COVID-19 tinnitus has not been treated successfully. As tinnitus may be related to SARS-CoV-2 neurological manifestations. This study aims to investigate if the dopamine receptor antagonists can be used effectively treat COVID-19 induced tinnitus.

Phase:

N/A

Details

Lead Sponsor:

Applied Biology, Inc.

Collaborator:

Jupiter Wellness, Inc.

Treatments:

Pimozide